Unnamed: 0,title,date,stock,sentiment
769017.0,A Look Into LeMaitre Vascular's Price Over Earnings,2020-06-09 14:44:00-04:00,LMAT,neutral
769018.0,"Stifel Maintains Hold on LeMaitre Vascular, Lowers Price Target to $25",2020-05-04 09:19:00-04:00,LMAT,negative
769019.0,"LeMaitre Vascular Q1 EPS $0.160 Beats $0.150 Estimate, Sales $30.551M Beat $30.300M Estimate",2020-04-30 16:07:00-04:00,LMAT,neutral
769020.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,LMAT,positive
769021.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,LMAT,negative
769022.0,"Canaccord Genuity Maintains Hold on LeMaitre Vascular, Lowers Price Target to $24",2020-04-14 13:41:00-04:00,LMAT,negative
769023.0,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",2020-04-14 07:59:00-04:00,LMAT,negative
769024.0,"Sidoti & Co. Maintains Buy on LeMaitre Vascular, Lowers Price Target to $34",2020-04-08 09:16:00-04:00,LMAT,negative
769025.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,LMAT,negative
769026.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,LMAT,negative
769027.0,"Sidoti & Co. Upgrades LeMaitre Vascular to Buy, Announces $38 Price Target",2020-03-16 09:04:00-04:00,LMAT,neutral
769028.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,LMAT,negative
769029.0,95 Biggest Movers From Friday,2020-02-10 05:20:00-05:00,LMAT,neutral
769030.0,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",2020-02-07 07:32:00-05:00,LMAT,negative
769031.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,LMAT,negative
769032.0,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",2020-02-02 13:04:00-05:00,LMAT,neutral
769033.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,LMAT,positive
769034.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,LMAT,positive
769035.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,LMAT,neutral
769036.0,Stocks That Hit 52-Week Highs On Thursday,2019-10-24 10:13:00-04:00,LMAT,neutral
769037.0,"Benzinga's Top Upgrades, Downgrades For October 24, 2019",2019-10-24 10:03:00-04:00,LMAT,positive
769038.0,"Lake Street Upgrades LeMaitre Vascular to Buy, Announces $40 Price Target",2019-10-24 09:06:00-04:00,LMAT,neutral
769039.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,LMAT,neutral
769040.0,First Analysis Downgrades LeMaitre Vascular to Outperform,2019-10-24 07:06:00-04:00,LMAT,neutral
769041.0,"LeMaitre Vascular Q3 EPS $0.25 Beats $0.21 Estimate, Sales $29.1M Beat $28.15M Estimate",2019-10-23 16:06:00-04:00,LMAT,neutral
769042.0,"The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data",2019-10-23 07:54:00-04:00,LMAT,negative
769043.0,"Benzinga's Top Upgrades, Downgrades For October 15, 2019",2019-10-15 10:18:00-04:00,LMAT,positive
769044.0,"Benzinga's Top Upgrades, Downgrades For October 14, 2019",2019-10-14 10:46:00-04:00,LMAT,positive
769045.0,First Analysis Upgrades LeMaitre Vascular to Strong Buy,2019-10-14 06:33:00-04:00,LMAT,positive
769046.0,LeMaitre Vascular Acquires Biologic Patch Business from Admedus for $15.5M,2019-10-13 19:14:00-04:00,LMAT,neutral
769047.0,"Benzinga's Top Upgrades, Downgrades For July 25, 2019",2019-07-25 09:48:00-04:00,LMAT,positive
769048.0,LeMaitre Vascular shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. First Analyst upgraded the company from Neutral to Outperform and announced a price target of $37 per share.,2019-07-25 09:31:00-04:00,LMAT,positive
769049.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,LMAT,negative
769050.0,"First Analysis Upgrades LeMaitre Vascular to Outperform, Announces $37 Price Target",2019-07-25 07:06:00-04:00,LMAT,neutral
769051.0,35 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-07-25 05:55:00-04:00,LMAT,neutral
769052.0,"LeMaitre Vascular Q2 EPS $0.23 Beats $0.21 Estimate, Sales $29.483M Beat $28.9M Estimate",2019-07-24 16:09:00-04:00,LMAT,neutral
769053.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,LMAT,neutral
769054.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,LMAT,neutral
769055.0,LeMaitre Vascular Guides Q2 Sales Of $28.4-29.2 Mln vs. $28.79 Estimate; Raises FY19 Revenue Guidance From $113-114.4 Mln To $113.5-114.7 Mln vs. $113.62 Mln Estimate;,2019-05-01 16:13:00-04:00,LMAT,neutral
769056.0,"LeMaitre Vascular Q1 EPS $0.17 Misses $0.19 Estimate, Sales $28.5M Beat $27.94M Estimate",2019-05-01 16:09:00-04:00,LMAT,negative
769057.0,"The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue",2019-05-01 07:39:00-04:00,LMAT,neutral
769058.0,75 Biggest Movers From Yesterday,2019-02-21 05:12:00-05:00,LMAT,neutral
769059.0,Mid-Afternoon Market Update: Crude Oil Up 1.5%; Kandi Technologies Shares Spike Higher,2019-02-20 14:45:00-05:00,LMAT,negative
769060.0,54 Stocks Moving In Wednesday's Mid-Day Session,2019-02-20 13:13:00-05:00,LMAT,neutral
769061.0,Mid-Day Market Update: LeMaitre Vascular Surges Following Strong Q4 Results; Sienna Biopharmaceuticals Shares Slide,2019-02-20 13:01:00-05:00,LMAT,positive
769062.0,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",2019-02-20 07:34:00-05:00,LMAT,negative
769063.0,"LeMaitre Vascular Sees Q1 EPS $0.18-$0.20 vs $0.20 Estimate, Sales $$27.7M-$28.5M vs $27.2M Est.; FY19 EPS $0.82-$0.86 vs $0.81 Est., Sales $113M-$114.4M vs $110.3M Est.",2019-02-19 16:31:00-05:00,LMAT,neutral
769064.0,"LeMaitre Vascular Q4 EPS $0.30 Beats $0.18 Estimate, Sales $28.389M Beat $25.9M Estimate",2019-02-19 16:30:00-05:00,LMAT,neutral
769065.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,LMAT,neutral
769066.0,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",2018-12-20 07:53:00-05:00,LMAT,positive
769067.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018",2018-12-19 12:43:00-05:00,LMAT,negative
769068.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,LMAT,positive
769069.0,"Stocks Trading Ex Dividend For Mon., Nov. 19, 2018",2018-11-19 10:13:00-05:00,LMAT,neutral
769070.0,"Stocks That Will Trade Ex Dividend Mon., Nov. 19, 2018",2018-11-16 10:35:00-05:00,LMAT,neutral
769071.0,"LeMaitre Vascular Reports Purchase Of Cardial Business Of BD For â‚¬2M In Cash, Liabilities",2018-10-24 16:57:00-04:00,LMAT,negative
769072.0,"Stocks Which Set New 52-Week Low Yesterday, October 10th",2018-10-11 09:11:00-04:00,LMAT,negative
769073.0,"Stocks Which Set New 52-Week Low Yesterday, October 9th",2018-10-10 11:01:00-04:00,LMAT,negative
769074.0,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",2018-10-10 07:56:00-04:00,LMAT,positive
769075.0,10 Biggest Price Target Changes For Monday,2018-10-08 09:38:00-04:00,LMAT,neutral
769076.0,"Stocks Which Set New 52-Week Low Friday, October 5th",2018-10-08 09:27:00-04:00,LMAT,negative
769077.0,"Roth Capital Upgrades LeMaitre Vascular To Buy, Lowers Price Target To $34",2018-10-08 08:21:00-04:00,LMAT,negative
769078.0,"Canaccord Genuity Maintains Hold on LeMaitre Vascular, Lowers Price Target to $32",2018-10-08 06:51:00-04:00,LMAT,negative
769079.0,46 Biggest Movers From Friday,2018-10-08 04:46:00-04:00,LMAT,neutral
769080.0,36 Stocks Moving In Friday's Mid-Day Session,2018-10-05 12:37:00-04:00,LMAT,neutral
769081.0,"The Daily Biotech Pulse: MediciNova Gets Orphan-Drug Status, KemPharm To Offer Shares, Emergent Buys Vaccine Maker",2018-10-05 08:35:00-04:00,LMAT,positive
769082.0,LeMaitre Vascular shares are down 15.1% after the company issued soft Q3 sales guidance.,2018-10-04 17:43:00-04:00,LMAT,positive
769083.0,"LeMaitre Vascular Reports Prelim. Q3 EPS $0.21 vs $0.21 Est., Sales $24.1M vs $26.01M Est.",2018-10-04 16:49:00-04:00,LMAT,neutral
769084.0,LeMaitre Vascular Reports Purchase Of Applied Medical Resources For $14.2M,2018-09-26 16:17:00-04:00,LMAT,neutral
769085.0,"Stocks Trading Ex Dividend For Tues., Aug. 21, 2018",2018-08-21 09:28:00-04:00,LMAT,neutral
769086.0,"LeMaitre Vascular Sees Q3 EPS $0.20-$0.22 vs $0.23 Est., Sales $25.6M-$26.4M vs $26.7M; FY18 EPS Outlook Cut To $1.05-$1.13 to $1.04-$1.11 vs $1.09 Est.",2018-07-26 16:34:00-04:00,LMAT,negative
769087.0,"LeMaitre Vascular Q2 EPS $0.43 Beats $0.42 Estimate, Sales $27M Miss $27.08M Estimate",2018-07-26 16:33:00-04:00,LMAT,negative
769088.0,"Lake Street Initiates Coverage On LeMaitre Vascular with Buy Rating, Announces $45 Price Target",2018-06-25 09:11:00-04:00,LMAT,neutral
769089.0,50 Biggest Movers From Yesterday,2018-04-27 05:10:00-04:00,LMAT,neutral
769090.0,LeMaitre Vascular's Lack Of Near-Term Catalysts Pushes Stifel To The Sidelines,2018-04-26 15:00:00-04:00,LMAT,negative
769091.0,Mid-Afternoon Market Update: Dow Rises 250 Points; Chipotle Shares Spike Higher,2018-04-26 14:32:00-04:00,LMAT,positive
769092.0,Benchmark Upgrades LeMaitre Vascular to Buy,2018-04-26 13:36:00-04:00,LMAT,neutral
769093.0,LeMaitre Vascular Shares Down 18.6% With Wednesday's Report Of Upbeat Q2 And FY18 EPS Guidance Overshadowed By Q1 Miss and Stifel Downgrade To Hold Earlier Today,2018-04-26 12:38:00-04:00,LMAT,positive
769094.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-04-26 12:25:00-04:00,LMAT,neutral
769095.0,Mid-Day Market Update: MarineMax Gains Following Q2 Results; Spectrum Brands Shares Slide,2018-04-26 12:05:00-04:00,LMAT,positive
769096.0,Mid-Morning Market Update: Markets Open Higher; Facebook Profit Tops Expectations,2018-04-26 10:18:00-04:00,LMAT,positive
769097.0,"Benzinga's Top Upgrades, Downgrades For April 26, 2018",2018-04-26 09:25:00-04:00,LMAT,positive
769098.0,Stifel Nicolaus Downgrades LeMaitre Vascular to Hold,2018-04-26 07:18:00-04:00,LMAT,neutral
769099.0,"LeMaitre Sees Q2 EPS $0.41 to $0.43 vs $0.25 Est., Sales $26.6M to $27.4M vs $28.2M Est.",2018-04-25 16:54:00-04:00,LMAT,neutral
769100.0,"LeMaitre Sees FY18 EPS $1.05 to $1.13 vs $0.98 Est., Sales $106M to $109M vs $111M Est.",2018-04-25 16:53:00-04:00,LMAT,neutral
769102.0,LeMaitre Vascular Divests General Surgery Product Lines To Symmetry Surgical For $7.4M,2018-04-05 16:51:00-04:00,LMAT,neutral
769103.0,"LeMaitre Vascular Sees Q1 EPS $0.19-$0.21 vs $0.20 Est., Sales $26M-$26.6M vs $26.64M Est.; FY18 EPS $0.96-$1 vs $0.88 Est., Sales $110M-$111.6M vs $111.25M Est.",2018-02-21 16:57:00-05:00,LMAT,neutral
769104.0,"LeMaitre Vascular Reports Q4 EPS $0.21 vs $0.20 Est., Sales $26.2M vs $26.23M Est.",2018-02-21 16:56:00-05:00,LMAT,neutral
769105.0,50 Biggest Movers From Friday,2017-10-30 05:13:00-04:00,LMAT,neutral
769106.0,45 Stocks Moving In Friday's Mid-Day Session,2017-10-27 12:32:00-04:00,LMAT,neutral
769107.0,Benchmark Downgrades LeMaitre Vascular to Hold,2017-10-27 09:33:00-04:00,LMAT,neutral
769108.0,LeMaitre Raises FY17 EPS Guidance From $0.79 To $0.83-$0.85,2017-10-26 16:47:00-04:00,LMAT,neutral
769109.0,LeMaitre Lowers FY17 Sales Guidance From $101.9M To $100.6M-$101.4M,2017-10-26 16:46:00-04:00,LMAT,negative
769110.0,"LeMaitre Sees Q4 EPS $0.19-$0.21, Sales $25.8M-$26.6M",2017-10-26 16:45:00-04:00,LMAT,neutral
769111.0,"LeMaitre Reports Q3 EPS $0.25 vs. $0.20 Est., Sales $24.8M vs. $25.5M Est.",2017-10-26 16:44:00-04:00,LMAT,neutral
769112.0,Mid-Afternoon Market Update: CyberOptics Drops After Q2 Results; Aaron's Shares Surge,2017-07-28 15:08:00-04:00,LMAT,positive
769113.0,18 Biggest Mid-Day Gainers For Friday,2017-07-28 12:39:00-04:00,LMAT,neutral
769114.0,Mid-Day Market Update: Boston Beer Surges On Earnings Beat; Destination Maternity Shares Slide,2017-07-28 12:11:00-04:00,LMAT,positive
769115.0,"LeMaitre Sees FY17 Sales ~$101.9M vs $100M Est., EPS $0.79 vs $0.70 Est.",2017-07-27 16:52:00-04:00,LMAT,neutral
769116.0,"LeMaitre Reports Q2 EPS $0.23 vs $0.17 Est., Sales $25.8M vs $25.4M Est.",2017-07-27 16:52:00-04:00,LMAT,neutral
769117.0,Mid-Afternoon Market Update: Abercrombie & Fitch Drops After Terminating Talks For Possible Sale; Hawaiian Telcom Shares Climb,2017-07-10 14:32:00-04:00,LMAT,positive
769118.0,12 Biggest Mid-Day Losers For Monday,2017-07-10 13:01:00-04:00,LMAT,negative
769119.0,Mid-Day Market Update: ClubCorp Surges Following Acquisition By Apollo Global; Cincinnati Bell Shares Drop,2017-07-10 12:04:00-04:00,LMAT,neutral
769120.0,Mid-Morning Market Update: Markets Mostly Flat; Helen of Troy Profit Beats Views,2017-07-10 10:13:00-04:00,LMAT,positive
769121.0,"Benzinga's Top Upgrades, Downgrades For July 10, 2017",2017-07-10 09:28:00-04:00,LMAT,positive
769122.0,Canaccord Genuity Downgrades LeMaitre Vascular to Hold,2017-07-10 07:14:00-04:00,LMAT,neutral
769123.0,Benchmark Downgrades LeMaitre Vascular to Hold,2017-07-10 07:14:00-04:00,LMAT,neutral
769124.0,S&P Dow Jones Indices Reports LeMaitre Vascular Will Replace First NBC Bank in S&P SmallCap 600,2017-05-01 17:18:00-04:00,LMAT,neutral
769125.0,Mid-Afternoon Market Update: LeMaitre Vascular Rises After Strong Q1 Results; Synchronoss Technologies Shares Plunge,2017-04-27 15:42:00-04:00,LMAT,positive
769126.0,20 Biggest Mid-Day Gainers For Thursday,2017-04-27 12:35:00-04:00,LMAT,neutral
769127.0,Mid-Day Market Update: Crude Oil Down 2%; GrubHub Shares Surge On Earnings Beat,2017-04-27 12:14:00-04:00,LMAT,negative
769128.0,"LeMaitre Q1 EPS $0.16 vs $0.15 Est., Sales $24.1M vs $23.49M Est.",2017-04-26 16:54:00-04:00,LMAT,neutral
769129.0,"First Analysis Initiates Coverage On LeMaitre Vascular With Overweight, Announces $29 Price Target",2017-03-21 07:24:00-04:00,LMAT,negative
769130.0,"LeMaitre Sees FY17 Sales Of ~$99M vs. $99.4M, Q1 Rev. ~$22.75M vs. $22.75M Est.",2017-02-21 16:12:00-05:00,LMAT,neutral
769131.0,"LeMaitre Reports Q4 EPS $0.13 vs. $0.15 Est., Revenue $23.3M vs. $23.5M Est.",2017-02-21 16:11:00-05:00,LMAT,neutral
769132.0,10 Stocks That Rallied Three Days On Increasing Volume,2016-12-12 06:29:00-05:00,LMAT,neutral
769133.0,LeMaitre Vascular Acquires Restore Flow Allografts For $14M,2016-11-10 17:20:00-05:00,LMAT,positive
769134.0,Mid-Afternoon Market Update: TTM Tech Climbs On Earnings Beat; Groupon Shares Plummet,2016-10-27 14:50:00-04:00,LMAT,positive
769135.0,20 Biggest Mid-Day Gainers For Thursday,2016-10-27 12:26:00-04:00,LMAT,neutral
769136.0,Mid-Day Market Update: GNC Falls After Weak Q3 Results; Ocwen Financial Shares Surge,2016-10-27 12:06:00-04:00,LMAT,negative
769137.0,"LeMaitre Sees Q4 Rev. ~$23.1M vs. Est. $23.4M, FY16 Rev. ~$89M vs. Est. $88.2M",2016-10-26 16:50:00-04:00,LMAT,neutral
769138.0,"LeMaitre Reports Q3 EPS $0.17 vs. Est. $0.15, Rev. $23.2M vs. Est. $22.2M",2016-10-26 16:48:00-04:00,LMAT,neutral
769139.0,Mid-Afternoon Market Update: Crude Oil Up 2.2%; OMNOVA Shares Drop On Earnings Miss,2016-09-22 15:29:00-04:00,LMAT,negative
769140.0,"25 Stocks Which Rallied Four Days, Then Sold Off Yesterday",2016-09-22 09:47:00-04:00,LMAT,neutral
769141.0,22 Stocks With Three-Day Increasing Volume,2016-09-21 09:16:00-04:00,LMAT,neutral
769142.0,7 Stocks Which Rallied Three Days On Increasing Volume,2016-09-21 08:54:00-04:00,LMAT,neutral
769143.0,"LeMaitre Vascular Reports Q2 EPS $0.14 vs $0.11 Est, Rev $22.4M vs $21.52M Est",2016-07-27 16:56:00-04:00,LMAT,neutral
769144.0,"LeMaitre Raises FY16 Sales Outlook to ~$85.7M vs $84.7M Est., Operating Income ~$14.3M",2016-05-02 16:40:00-04:00,LMAT,neutral
769145.0,"LeMaitre Sees Q2 Sales ~$21.6M vs $21.5M Est., Operating Income ~$3.2M",2016-05-02 16:39:00-04:00,LMAT,neutral
769146.0,"LeMaitre Reports Q1 EPS $0.11 vs. Est. $0.10, Rev. $20.3M vs. Est. $20.2M",2016-05-02 16:06:00-04:00,LMAT,neutral
769147.0,"Cowen & Company Maintains Outperform on LeMaitre Vascular, Raises PT to $93.00",2016-04-21 07:41:00-04:00,LMAT,neutral
769148.0,LeMaitre Acquires ProCol Vascular Bioprosthesis For $665K Plus 3 Year Royalty,2016-03-18 14:31:00-04:00,LMAT,neutral
769149.0,"LeMaitre Sees Q1 Rev. $20.2M vs. Est. $20.3M, FY16 Rev. $84.7M vs. Est. $84.5M",2016-02-24 16:44:00-05:00,LMAT,neutral
769150.0,"LeMaitre Reports Q4 EPS $0.13 vs. Est. $0.09, Rev. $20.5M vs. Est. $20.1M",2016-02-24 16:43:00-05:00,LMAT,neutral
769151.0,Roth Capital Says Medical Device Industry To Be 'one of the big winners' If MDET Suspension Proposal Becomes Law,2015-12-16 10:35:00-05:00,LMAT,positive
769152.0,"LeMaitre Vacular Reports EPS $0.11 Vs Est $0.08, Sales $19.0M Vs Est $18.82M",2015-10-27 16:01:00-04:00,LMAT,neutral
769153.0,LeMaitre Vascular Reports Registration of TRIVEX System in China,2015-10-16 16:02:00-04:00,LMAT,neutral
769154.0,LeMaitre Vascular Hires Michael Wijas Vice President of Sales for the Americas,2015-09-09 09:03:00-04:00,LMAT,neutral
769155.0,"Brean Capital Maintains Buy on LeMaitre Vascular, Raises PT to $13.00",2015-07-29 06:24:00-04:00,LMAT,neutral
769156.0,LeMaitre Sees Q3 Sales $18.8M vs $18M Est.; Sees FY15 Sales $77.3M vs $75M Est.,2015-07-28 16:42:00-04:00,LMAT,neutral
769157.0,"LeMaitre Vacular Reports Q2 EPS $0.10 Vs Est $0.07, Sales $19.9M Vs Est $18.83M",2015-07-28 16:09:00-04:00,LMAT,neutral
769158.0,Stocks Hitting 52-Week Highs,2015-06-30 10:29:00-04:00,LMAT,neutral
769159.0,"Dougherty & Company Initiates Coverage on LeMaitre Vascular at undefined, Announces $14.00 PT",2015-06-19 09:27:00-04:00,LMAT,neutral
769160.0,EARLIER: LeMaitre Expecting Q2 Sales ~$18.9M vs $18.83M Est.; Raised FY15 Sales Guidance to $75M vs $74.5M Est.,2015-04-28 17:45:00-04:00,LMAT,neutral
769161.0,"LeMaitre Vacular Reports Q1 EPS $0.08 Vs Est $0.05, Sales $18.9M Vs Est $17.76M",2015-04-28 16:06:00-04:00,LMAT,neutral
769162.0,"LeMaitre Vascular Reports Q4 EPS $0.11 Vs Est $0.07, Sales $18.7M Vs Est $18.9M",2015-02-25 16:07:00-05:00,LMAT,neutral
769163.0,"LeMaitre Vascular, Inc. Reports Q3 EPS of $0.05, Inline; Revenue of $17.50M vs $17.09M Est",2014-10-28 16:15:00-04:00,LMAT,neutral
769164.0,Top 4 Small-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Dividend Yield,2014-10-01 04:31:00-04:00,LMAT,positive
769165.0,LeMaitre Vascular Announces Purchase of Angioscope Product Line from Applied Material for $420K,2014-09-19 16:06:00-04:00,LMAT,neutral
769166.0,The Benchmark Company Sees Xenotis Acquisition As Good For LeMaitre Vascular,2014-08-19 09:57:00-04:00,LMAT,positive
769167.0,LeMaitre Acquires Omniflow II Biologic Graft,2014-08-18 10:15:00-04:00,LMAT,neutral
769168.0,"LeMaitre Sees Q3 Sales $17.1M, FY 2014 Sales $70.1M",2014-07-29 17:00:00-04:00,LMAT,neutral
769169.0,LeMaitre Announces Sales of $18.2M; EPS of $0.08,2014-07-29 16:59:00-04:00,LMAT,neutral
769170.0,UPDATE: Stifel Initiates Coverage On LeMaitre Vascular On Good Investment Opportunity,2014-06-24 08:36:00-04:00,LMAT,positive
769171.0,"Stifel Nicolaus Initiates Coverage on LeMaitre Vascular, Inc. at Buy, Announces $11.00 PT",2014-06-24 06:48:00-04:00,LMAT,neutral
769172.0,Lemaitre Vascular Priced 1.43M Shares at $7/Share for Net Proceeds $9.1M,2014-05-30 08:32:00-04:00,LMAT,positive
769173.0,Lemaitre Vascular Announces Offering of Common Stock,2014-05-29 16:27:00-04:00,LMAT,neutral
769174.0,Benzinga's Top Initiations,2014-05-19 07:53:00-04:00,LMAT,positive
769175.0,"Brean Capital Initiates Coverage on LeMaitre Vascular, Inc. at Buy, Announces $11.00 PT",2014-05-19 06:32:00-04:00,LMAT,neutral
769176.0,"LeMaitre Vascular, Inc. Reports Q1 EPS of $(0.01) vs $0.02 Est; Revenue of $16.80M vs $17.04M Est",2014-04-29 16:09:00-04:00,LMAT,neutral
769177.0,LeMaitre Raises Qtr. Dividend from $0.03 to $0.035/Share,2014-02-25 16:09:00-05:00,LMAT,neutral
769178.0,"LeMaitre Vascular, Inc. Reports Q4 EPS of $0.05, Inline; Revenue of $17.90M vs $16.47M Est",2014-02-25 16:07:00-05:00,LMAT,neutral
769179.0,"LeMaitre Announces Will Sell Direct-to-Hospital in Australia, Norway",2014-01-02 16:21:00-05:00,LMAT,neutral
769180.0,UPDATE: Benchmark Company Initiates Coverage on LeMaitre Vascular on Multiple Positive Factors,2013-10-24 10:35:00-04:00,LMAT,positive
769181.0,Benzinga's Top Initiations,2013-10-24 07:39:00-04:00,LMAT,positive
769182.0,"Benchmark Initiates Coverage on LeMaitre Vascular, Inc. at Buy, Announces $9.00 PT",2013-10-24 07:23:00-04:00,LMAT,neutral
769183.0,"Roth Capital Initiates Coverage on LeMaitre Vascular, Inc. at Buy, Announces $10.00 PT",2013-10-10 07:17:00-04:00,LMAT,neutral
769184.0,LeMaitre Vascular Buys Inavein for $2.5M,2013-08-28 09:13:00-04:00,LMAT,neutral
769185.0,"Barrington Research Maintains Outperform on LeMaitre Vascular, Inc., Raises PT to $8.50",2013-08-01 10:03:00-04:00,LMAT,neutral
769186.0,"LeMaitre Vascular, Inc. Reports Q2 EPS of $0.06 vs $0.05 Est; Revenue of $16.0M",2013-07-30 16:14:00-04:00,LMAT,neutral
769187.0,Lemaitre Vascular Buys Clinical Instruments for $1.1M,2013-07-09 14:04:00-04:00,LMAT,neutral
769188.0,"LeMaitre Vascular, Inc. Reports Q1 EPS of $0.05 vs $0.03 Est; Revenue of $15.38M vs $14.94M Est; Raises outlook",2013-04-30 16:13:00-04:00,LMAT,neutral
769189.0,"LeMaitre Vascular, Inc. Sees FY2013 Sales $61.50M vs $60.0M Est",2013-02-26 16:25:00-05:00,LMAT,neutral
769190.0,"LeMaitre Vascular, Inc. Sees Q1 Sales $15.0M vs $14.0M Est",2013-02-26 16:24:00-05:00,LMAT,neutral
769191.0,"LeMaitre Vascular, Inc. Reports Q4 EPS of $0.04 vs $0.06 Est; Revenue of $14.80M",2013-02-26 16:24:00-05:00,LMAT,neutral
769192.0,"Lemaitre Vascular Says Michael Jackson, William Thorndike Resign from Board",2012-12-10 16:17:00-05:00,LMAT,negative
769193.0,"UPDATE: Barrington Research Initiates LeMaitre Vascular at Outperform on Valuation, Stable Outlook  ",2012-11-02 12:31:00-04:00,LMAT,positive
769194.0,"Barrington Research Initiates Coverage on LeMaitre Vascular at Outperform, Announces PT of $7.50",2012-11-02 10:29:00-04:00,LMAT,neutral
769195.0,"Barrington Research Initiates Coverage on LeMaitre Vascular at Outperform, Announces PT of $7.50",2012-11-02 08:43:00-04:00,LMAT,neutral
769196.0, UPDATE: Canaccord Genuity Lowers LeMaitre Vascular's PT ,2012-05-03 09:33:00-04:00,LMAT,negative
769197.0,"Canaccord Maintains LeMaitre Vascular at Buy, Lowers PT from $7.5 to $7",2012-05-03 07:16:00-04:00,LMAT,negative
769198.0,UPDATE: Canaccord Lowers LeMaitre Vascular's PT,2012-02-28 09:53:00-05:00,LMAT,negative
769199.0,Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products,2011-07-18 08:30:00-04:00,LMAT,positive
769200.0,"NASDAQ Stocks Hitting 52-Week Highs (INTX, LMAT, MNRO, THRD)",2010-08-18 12:14:00-04:00,LMAT,neutral
769201.0,"Stocks Hitting 52-Week Highs (CHRW, ADVS, LMAT, USNA)",2010-07-28 13:45:00-04:00,LMAT,neutral
